{"title":"Charcot神经关节病的发病机制:目前的概念。","authors":"Shelly A M Larson, Patrick R Burns","doi":"10.3402/dfa.v3i0.12236","DOIUrl":null,"url":null,"abstract":"<p><p>The pathogenesis of Charcot neuroarthropathy (CN) has been poorly understood by clinicians and scientists alike. Current researchers have made progress toward understanding the cause of CN and possible treatment options. The authors review the current literature on the pathogenesis of this debilitating disorder and attempt to explain the roles of inflammation, bone metabolism, and advanced glycation end products.</p>","PeriodicalId":45385,"journal":{"name":"Diabetic Foot & Ankle","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3402/dfa.v3i0.12236","citationCount":"48","resultStr":"{\"title\":\"The pathogenesis of Charcot neuroarthropathy: current concepts.\",\"authors\":\"Shelly A M Larson, Patrick R Burns\",\"doi\":\"10.3402/dfa.v3i0.12236\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The pathogenesis of Charcot neuroarthropathy (CN) has been poorly understood by clinicians and scientists alike. Current researchers have made progress toward understanding the cause of CN and possible treatment options. The authors review the current literature on the pathogenesis of this debilitating disorder and attempt to explain the roles of inflammation, bone metabolism, and advanced glycation end products.</p>\",\"PeriodicalId\":45385,\"journal\":{\"name\":\"Diabetic Foot & Ankle\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.3402/dfa.v3i0.12236\",\"citationCount\":\"48\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetic Foot & Ankle\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3402/dfa.v3i0.12236\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2012/1/10 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"Health Professions\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetic Foot & Ankle","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3402/dfa.v3i0.12236","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/1/10 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Health Professions","Score":null,"Total":0}
The pathogenesis of Charcot neuroarthropathy: current concepts.
The pathogenesis of Charcot neuroarthropathy (CN) has been poorly understood by clinicians and scientists alike. Current researchers have made progress toward understanding the cause of CN and possible treatment options. The authors review the current literature on the pathogenesis of this debilitating disorder and attempt to explain the roles of inflammation, bone metabolism, and advanced glycation end products.